Clinical Trial Detail

NCT ID NCT04108481
Title Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer (iRE-C)
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Iowa
Indications

colorectal cancer

Therapies

Durvalumab

Age Groups: adult senior

No variant requirements are available.